• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Dalcetrapib

Dalcetrapib

Product ID D0244
Cas No. 211513-37-0
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $125.00 In stock
10 mg $225.00 In stock
25 mg $495.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Dalcetrapib is a cholesterol ester transfer protein (CETP) inhibitor that exhibits anti-atherosclerotic activity. In a clinical setting, dalcetrapib increases HDL levels but has exhibited mixed results regarding cardiovascular disease risk reduction.

Product Info

Cas No.

211513-37-0

Purity

≥98%

Formula

C23H35NO2S

Formula Wt.

389.60

Chemical Name

Dalcetrapib

Synonym

JTT-705, RO4607381

Solubility

DMSO 78 mg/mL Ethanol 78 mg/mL Water Insoluble

Appearance

White Powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

D0244 MSDS PDF

Info Sheet

D0244 Info Sheet PDF

References

Schwartz GG, Olsson AG, Abt M, et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med. 2012 Nov 29;367(22):2089-99. PMID: 23126252.

Goldberg AS, Hegele RA. Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib. Drug Des Devel Ther. 2012;6:251-9. PMID: 23055695.

Robinson JG. Dalcetrapib: a review of Phase II data. Expert Opin Investig Drugs. 2010 Jun;19(6):795-805. PMID: 20465364.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • R3577

    Ritonavir

    HIV protease inhibitor.
    ≥98%
  • H0100

    Hemagglutinin-1 Peptide

    Peptide, hemagglutinin epitope.
    ≥95%
  • R580665

    Roquefortine C

    Roquefortine C is a mycotoxin produced by various ...
  • S0459

    SB-590885

    B-Raf inhibitor.
    ≥97%
  • D3302

    Diaveridine Hydrochloride

    Coccidiostat; dihydrofolate reductase inhibitor.
    ≥98%
  • H189921

    1,2,3,4,5,6-Hexabromocyclohexane

    1,2,3,4,5,6-hexabromocyclohexane directly inhibits...
    ≥98%
  • L1881

    Leuprolide Acetate

    GnRH analog; GnRH1 agonist.
    ≥98%
  • T2833

    1-Thio-β-D-glucose Tetraacetate

    Imaging agent; Maillard reaction inhibitor.
    ≥98%
  • P7000

    PR-619

    Deubiquitinating enzyme inhibitor.
    ≥98%
  • A1332

    Adipokinetic Hormone II from Locusta migratoria

    Neuropeptide found in Locusta migratoria.
    ≥98%
  • I7357

    Isorhamnetin

    Flavonol found in Tagetes.
    ≥98%
  • L0350

    Lamivudine

    Nucleoside (thymidine) analog; RT inhibitor.
    ≥98%
  • P7060

    Protocatechuic Acid Ethyl Ester

    Dihydroxyphenolic acid found in cruciferous vegeta...
    ≥98%
  • P6903

    Prasugrel

    Thienopyridine; P2Y12 antagonist.
    ≥98%
  • T1754

    Tenatoprazole

    H+/K+ ATPase inhibitor.
    ≥98%
  • L0250

    Laminin Peptide SIKVAV

    Laminin-derived hexapeptide.
    ≥98%
  • C9610

    D-Cycloserine

    NMDA partial agonist, D-Ala-D-Ala ligase inhibitor...
    ≥98%
  • C9611

    Cyclosporin A

    Cyclic peptide; calcineurin inhibitor.
    ≥98%
  • M5610

    Moclobemide

    MAO-A inhibitor.
    ≥98%
  • Z0146

    Z-Ala-Ala-Leu-pNA

    Proteinase subtrate.
    ≥95%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only